Overall, the insights gained from this study highlight the importance of ongoing research into the molecular underpinnings of tauopathies and reinforce the promise of targeted therapeutic interventions in the context of rebalancing tau isoform levels. The gene discussed is MAPT; the disease is tauopathy.